title: Barth Syndrome: Connecting Cardiolipin to Cardiomyopathy.
abstract: The Barth syndrome (BTHS) is caused by an inborn error of metabolism that manifests characteristic phenotypic features including altered mitochondrial membrane phospholipids, lactic acidosis, organic acid-uria, skeletal muscle weakness and cardiomyopathy. The underlying cause of BTHS has been definitively traced to mutations in the tafazzin (TAZ) gene locus on chromosome X. TAZ encodes a phospholipid transacylase that promotes cardiolipin acyl chain remodeling. Absence of tafazzin activity results in cardiolipin molecular species heterogeneity, increased levels of monolysocardiolipin and lower cardiolipin abundance. In skeletal muscle and cardiac tissue mitochondria these alterations in cardiolipin perturb the inner membrane, compromising electron transport chain function and aerobic respiration. Decreased electron flow from fuel metabolism via NADH ubiquinone oxidoreductase activity leads to a buildup of NADH in the matrix space and product inhibition of key TCA cycle enzymes. As TCA cycle activity slows pyruvate generated by glycolysis is diverted to lactic acid. In turn, Cori cycle activity increases to supply muscle with glucose for continued ATP production. Acetyl CoA that is unable to enter the TCA cycle is diverted to organic acid waste products that are excreted in urine. Overall, reduced ATP production efficiency in BTHS is exacerbated under conditions of increased energy demand. Prolonged deficiency in ATP production capacity underlies cell and tissue pathology that ultimately is manifest as dilated cardiomyopathy.
authors.affiliation: Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA, 94609, USA.
authors.forename: Nikita
authors.initials: N
authors.lastname: Ikon
authors.affiliation: Children's Hospital Oakland Research Institute, 5700 Martin Luther King Jr. Way, Oakland, CA, 94609, USA. rryan@chori.org.
authors.forename: Robert O
authors.initials: RO
authors.lastname: Ryan
mesh_terms: D000217:Acyltransferases; D000255:Adenosine Triphosphate / Q000378:metabolism; D056889:Barth Syndrome / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D002308:Cardiolipins / Q000378:metabolism*; D004579:Electron Transport; D006801:Humans; D008928:Mitochondria / Q000378:metabolism; D009154:Mutation; D009206:Myocardium / Q000378:metabolism*; D014157:Transcription Factors / Q000235:genetics*
chemical_list: D002308:Cardiolipins; D014157:Transcription Factors; D000255:Adenosine Triphosphate; D000217:Acyltransferases; C108675:TAFAZZIN protein, human
keywords: 3-Methylglutaconic acid; Barth syndrome; Cardiolipin; Cori cycle; Dilated cardiomyopathy; Electron transport chain; Inner mitochondrial membrane; Lactic acid; NADH oxidation; Organic aciduria; Tafazzin